| 000 | 01129 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250513125901.0 | ||
| 264 | 0 | _c19971125 | |
| 008 | 199711s 0 0 eng d | ||
| 022 | _a1054-3589 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGoldstein, D S | |
| 245 | 0 | 0 |
_aNovel catecholaminergic systems. Overview. _h[electronic resource] |
| 260 |
_bAdvances in pharmacology (San Diego, Calif.) _c1998 |
||
| 300 |
_a819-24 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCatechol O-Methyltransferase _xmetabolism |
| 650 | 0 | 4 |
_aDopamine _xphysiology |
| 650 | 0 | 4 |
_aEpinephrine _xmetabolism |
| 650 | 0 | 4 |
_aEstrogens, Catechol _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLevodopa _xpharmacology |
| 650 | 0 | 4 |
_aNeurons _xphysiology |
| 650 | 0 | 4 |
_aNeurotransmitter Agents _xphysiology |
| 650 | 0 | 4 |
_aNorepinephrine _xmetabolism |
| 650 | 0 | 4 | _aOrgan Specificity |
| 650 | 0 | 4 |
_aPhenylethanolamine N-Methyltransferase _xmetabolism |
| 650 | 0 | 4 |
_aTyrosine 3-Monooxygenase _xmetabolism |
| 773 | 0 |
_tAdvances in pharmacology (San Diego, Calif.) _gvol. 42 _gp. 819-24 |
|
| 999 |
_c9301215 _d9301215 |
||